Alyssa Carroll joined Acumen as a Clinical Trial Manager in 2022. Alyssa has over 7 years’ experience supporting Neurodegenerative research, including working on global Phase 3 Alzheimer’s Disease trials for Eli Lilly and Phase 3b/4 Alzheimer’s Disease trials for Biogen. She has contributed as a Clinical Monitor, Clinical Monitor Manger and Clinical Lead for these trials. Alyssa has demonstrated success in clinical trial oversight including: site activation and management, creating and maintaining study plans, and organizational process improvement. Alyssa received her MS in Anatomy and Neurobiology from Boston University School of Medicine in 2016.